Atlas Trials

X-Linked Hypohidrotic Ectodermal Dysplasia

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch X-Linked Hypohidrotic Ectodermal Dysplasia

RecordFirmDate
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia (NCT02099552)Edimer Pharmaceuticals2014-04-01
Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002 (NCT01992289)Edimer Pharmaceuticals2014-03-01
Phenotypic Properties in Individuals Affected With XLHED (NCT01871714)Edimer Pharmaceuticals2013-05-01
Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) (NCT01775462)Edimer Pharmaceuticals2013-04-01
Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status (NCT01629940)Edimer Pharmaceuticals2012-06-01
A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200 (NCT01564225)Edimer Pharmaceuticals2012-05-01
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012) (NCT01629927)Edimer Pharmaceuticals2012-03-01
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey (NCT01398813)Edimer Pharmaceuticals2011-07-01
Sweat Duct Imaging in Mother/Newborn Dyads (NCT01342133)Edimer Pharmaceuticals2011-04-01
Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype (NCT01398397)Edimer Pharmaceuticals2011-04-01
Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia (NCT01308333)University Hospital Erlangen2011-04-01
Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia (NCT01135888)University Hospital Erlangen2009-04-01

Track X-Linked Hypohidrotic Ectodermal Dysplasia automatically

Every clearance here is in the API, with alerts when new ones post.